Phase 1b trial to study the effect of Ch-mAb7F9 in methamphetamine using subjects.

Trial Profile

Phase 1b trial to study the effect of Ch-mAb7F9 in methamphetamine using subjects.

Planning
Phase of Trial: Phase I

Latest Information Update: 26 Apr 2016

At a glance

  • Drugs Ch-mAb7F9 (Primary)
  • Indications Drug abuse
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 26 Apr 2016 New trial record
    • 16 Aug 2013 According to a InterveXion media release, company has been granted a meeting with FDA in January 2014 to review this Phase 1b study protocol.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top